Loading...
OTCM
MJNA
Market cap1mUSD
Jul 09, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-99.90%
IPO
-100.00%
Name

Medical Marijuana Inc

Chart & Performance

D1W1MN
OTCM:MJNA chart
P/E
P/S
0.09
EPS
Div Yield, %
Shrs. gr., 5y
30.64%
Rev. gr., 5y
-23.30%
Revenues
12m
-16.42%
12,96660,4375,193,6545,059,92414,522,8949,215,3668,003,94326,522,54659,825,45075,560,02146,936,71834,123,03625,098,94116,810,84614,906,51512,458,496
Net income
-935k
L+45.78%
-177,66203,233,62324,611,419-4,488,35925,970,967-25,908,212-148,104,910-202,933,76084,404,176-95,778,779-4,770,766-15,349,375-5,083,519-641,595-935,305
CFO
-1m
L
-156,9080-3,619,420570,110-7,092,00513,384,174-19,613,376-155,080,543-197,596,86686,265,565-95,945,802-4,475,312-14,752,842-2,541,452977,299-1,352,035

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 2005 and based in San Diego, California, Medical Marijuana, Inc. operates as an investment holding entity primarily focused on the cannabinoid-based health and wellness industry. The company specializes in the development, marketing, and global distribution of hemp oils rich in naturally occurring cannabinoids, including CBD, alongside a variety of other non-psychoactive cannabidiol products. It also innovates with cannabis/cannabinoid-infused chewing gum, specifically formulated for the therapeutic management of pain and various other medical conditions. Beyond its core product offerings, the firm commits significant resources to research and development. This includes exploring novel therapeutic agents designed to mitigate oxidative stress, modulate immune responses, and provide neuroprotection. It also offers a comprehensive range of dietary supplements, skincare solutions, and prescription-grade hemp oils, distributed under its well-known Kannaway and HempMeds brands. Furthermore, Medical Marijuana, Inc. implements proprietary methodologies for testing, genetic selection, labeling, packaging, tracking, production, and standardization across the medicinal cannabinoid sector. Its product portfolio extends to include RSHO oil, addressing diverse health concerns, as well as a line of plant-based, non-GMO pet products that cater to animal health, recreation, and environmentally conscious needs.
IPO date
Jun 21, 2004
Employees
91
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT